Please login to the form below

Not currently logged in
Email:
Password:

Boehringer Ingelheim and Lilly launch diabetes education campaign

Follows the partnership’s filing of its SGLT-2 inhibitor for European approval

Boehringer Ingelheim and Lilly have developed a joint education campaign about the role of sodium glucose co-transporters (SGLT) in maintaining blood sugar balance for type 2 diabetes patients.

The campaign has been designed to provide healthcare professionals (HCPs) with a better understanding of the emerging science of using SGLTs to maintain glucose homeostasis, or blood sugar balance, which enables glucose entering the kidneys to find its way back into the bloodstream instead of being passed in the urine.

The initiative includes a microsite - www.sglt.com - featuring a short educational video, Glucose Perspectives, which was created by the Royal Society for the encouragement of Arts, Manufacturing and Commerce (RSA). Viewers are invited to sign up for further learning options that will be offered throughout the year.

“The contribution of insulin resistance and impaired beta-cell function in the physiopathology of type 2 diabetes mellitus has been extensively studied,” said Christophe Arbet-Engels, MD, PhD, vice president, metabolic-clinical development and medical affairs, Boehringer Ingelheim.

“The contributing role of persistently high glucose levels in the progression of type 2 diabetes has led to the need for a better understanding of how glucose is reabsorbed by the kidneys.

“The Boehringer Ingelheim and Lilly Diabetes alliance is very pleased to offer healthcare professionals an educational resource they can use at their convenience to gain greater knowledge of this process.”

Germany-headquartered Boehringer Ingelheim and US-based Eli Lilly announced a diabetes alliance at the beginning of 2011, which has focused on three pipeline compounds representing several of the largest treatment classes.

Earlier this year, the partnership filed its new SGLT-2 inhibitor, Empagliflozin, for European approval.

8th May 2013

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics